Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma-Reference-Cited by-同舟云学术

Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma

Published:2020-09-01 Issue:9 Volume:155 Page:832
ISSN:2168-6254
Container-title:JAMA Surgery
language:en
Short-container-title:JAMA Surg

Author:

Perri Giampaolo¹,Prakash Laura¹,Qiao Wei²,Varadhachary Gauri R.³,Wolff Robert³,Fogelman David³,Overman Michael³,Pant Shubham³,Javle Milind³,Koay Eugene J.⁴,Herman Joseph⁴,Kim Michael¹,Ikoma Naruhiko¹,Tzeng Ching-Wei¹,Lee Jeffrey E.¹,Katz Matthew H. G.¹

Affiliation:

1. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston

2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston

3. Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston

4. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

Surgery

Link

https://jamanetwork.com/journals/jamasurgery/articlepdf/2768334/jamasurgery_perri_2020_oi_200039_1598967263.39795.pdf

Reference25 articles.

1. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.;Conroy;N Engl J Med,2011

2. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.;Von Hoff;N Engl J Med,2013

3. Preoperative therapy and pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a 25-year single-institution experience.;Cloyd;J Gastrointest Surg,2017

4. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.;Tempero;J Natl Compr Canc Netw,2017

5. Potentially curable pancreatic cancer: American Society of Clinical Oncology clinical practice guideline.;Khorana;J Clin Oncol,2016

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Relationship between Treatment Response and Overall Survival in Borderline, Non-Resectable and Resectable Pancreatic Cancer Patients Treated with Neoadjuvant FOLFIRINOX;Journal of Clinical Medicine;2024-09-02

2. Impact of neoadjuvant chemoradiotherapy on pathologic response in pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.;Pancreatology;2024-09

3. Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab‐paclitaxel chemotherapy: A multicenter retrospective cohort study (PC‐CURE‐1);Journal of Hepato-Biliary-Pancreatic Sciences;2024-08-16

4. Pancreatic Cancer: A Retrospective Study From the Najran Region of Saudi Arabia;Cureus;2024-07-29

5. The systematic role of pancreatic cancer exosomes: distant communication, liquid biopsy and future therapy;Cancer Cell International;2024-07-25